SULFONYLUREAS - EFFECTS IN-VIVO AND IN-VITRO

被引：69
作者：
ROTH, J
PROUT, TE
GOLDFINE, ID
WOLFE, SM
MUENZER, J
GRAUER, LE
MARCUS, ML
机构：
来源：
ANNALS OF INTERNAL MEDICINE | 1971年 / 75卷 / 04期
关键词：
D O I：
10.7326/0003-4819-75-4-607
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：607 / +
页数：1
相关论文
共 70 条
[1]  
ARDLIE NG, 1967, THROMB DIATH HAEMOST, V18, P670
[2]  
ASHMORE J, 1956, METABOLISM, V5, P774
[3]   9 YEARS EXPERIENCE WITH TOLBUTAMIDE IN TREATMENT OF DIABETES [J].
BALODIMOS, MC ;
CAMERINI.RA ;
MARBLE, A .
METABOLISM, 1966, 15 (11) :957-+
[4]   POTENTIATION OF ANTIDIURETIC EFFECT OF VASOPRESSIN BY CHLORPROPAMIDE [J].
BERNDT, WO ;
MILLER, M ;
KETTYLE, WM ;
VALTIN, H .
ENDOCRINOLOGY, 1970, 86 (05) :1028-&
[5]  
BLOODWORTH JMB, 1963, METABOLISM, V12, P287
[6]  
BORSTEIN J, 1957, NATURE, V179, P534
[7]   BLOOD DYSCRASIAS ASSOCIATED WITH TOLBUTAMIDE THERAPY [J].
BROD, RC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1959, 171 (03) :296-297
[8]   CHLORPROPAMIDE AND TOLBUTAMIDE INHIBITION OF ADENOSINE 3'5' CYCLIC MONOPHOSPHATE PHOSPHODIESTERASE [J].
BROOKER, G ;
FICHMAN, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1971, 42 (05) :824-&
[9]  
BROWN J, 1956, METABOLISM, V5, P813
[10]  
BUTCHER RW, 1962, J BIOL CHEM, V237, P1244
1234567